Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/11/2019
SIETES contiene 92833 citas

 
 
 1 a 20 de 5690 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Garmendia CA, Gorra LN, Rodríguez AL, Trepka MJ, Veledar E, Madhivanan P. Evaluation of the inclusion of studies identified by the FDA as having falsified data in the results of meta-analyses. The example of the apixaban trials. JAMA Intern Med 2019;179:4 de marzo. [Ref.ID 103094]
2.Enlace a cita original Cita con resumen
Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten J-P, Jones PB, Kirkbride JB, Rutten BPF, de Haan L, Sham PC, Van Os J, Lewis CM, Lynskey M, Morgan C, Murray R, FRS the EU-GEI WP2 Group. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. The Lancet Psychiatry 2019:19 de marzo. [Ref.ID 103060]
3.Enlace a cita originalTiene citas relacionadas Cita con resumen
Agarwal A, Ioannidis JPA. PREDIMED trial of Mediterranean diet: retracted, republished, still trusted?. BMJ 2019;364:7 de febrero. [Ref.ID 103032]
4.Enlace a cita original Cita con resumen
Avery AJ, Bell BG. Rationalising medications through deprescribing. BMJ 2019;364:7 de febrero. [Ref.ID 103031]
5.Enlace a cita originalTiene citas relacionadas Cita con resumen
Pacurariu A, Plueschke K, Olmo CA, Kurz X. Imposed registries within the European postmarketing surveillance system: Extended analysis and lessons learned for regulators. Pharmacoepidemiol Drug Saf 2018;27:julio. [Ref.ID 102879]
6.Enlace a cita original Cita con resumen
Ramaekers JG. Driving under the influence of cannabis. An increasing public health concern. JAMA 2018;319:10 de abril. [Ref.ID 102668]
7.Enlace a cita original Cita con resumen
Charlton RA, Bettoli V, Bos HJ, Engeland A, Garne E, Gini R, Hansen AV, de Jong-van den Berg LTW, Jordan S, Klungsøyr K, Neville AJ, Pierini A, Puccini A, Sinclair M, Dolk DTH. The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures. Eur J Clin Pharmacol 2018;74:abril. [Ref.ID 102561]
8.Enlace a cita original Cita con resumen
Ferrajolo C, Scavone C, Donati M, Bortolami O, Stoppa G, Motola D, Vannacci A, Mugelli A, Leone R, Capuano A, on behalf of DILI-IT Study Group. Antidepressant-induced acute liver injury: a case-control study in an Italian inpatient population. Drug Saf 2018;41:enero. [Ref.ID 102527]
9.Enlace a cita original Cita con resumen
Gellad WF, Thorpe CT, Steiner JF, Voils CI. The myths of medication adherence. Pharmacoepidemiol Drug Saf 2017;27:diciembre. [Ref.ID 102186]
10. Cita con resumen
VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the e-value . Ann Intern Med 2017;167:268-74. [Ref.ID 102038]
11. Cita con resumen
de Boissieu P, Kanagaratnam L, Mahmoudi R, Morel A, Dramé M, Trenque T. Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review. Eur J Clin Pharmacol 2017;73:517-23. [Ref.ID 101992]
12. Cita con resumen
Waade RB, Molden E, Martinsen MI, Hermann M, Ranhoff AH. Psychotropics and weak opioid analgesics in plasma samples of older hip fracture patients – Detection frequencies and consistency with drug records. Br J Clin Pharmacol 2017;83:1397-404. [Ref.ID 101985]
13. Cita con resumen
Dimmitt S, Stampfer H, Martin JH. When less is more – Efficacy with less toxicity at the ED50. Br J Clin Pharmacol 2017;83:1365-8. [Ref.ID 101984]
14. Cita con resumen
Billionnet C, Alla F, Bérigaud É, Pariente A, Maura G. Identifying atrial fibrillation in outpatients initiating oral anticoagulants based on medico-administrative data: results from the French national healthcare databases . Pharmacoepidemiol Drug Saf 2017;26:535-43. [Ref.ID 101959]
15. Cita con resumen
Walsh EK, Hansen CR, Sahm LJ, Kearney PM, Doherty E, Bradley CP. Economic impact of medication error: a systematic review. Pharmacoepidemiol Drug Saf 2017;26:481-97. [Ref.ID 101957]
16. Cita con resumen
Pacurariu AC, Coloma PM, Gross-Martirosyan L, Sturkenboom MC, Straus SM. Decision making in drug safety — A literature review of criteria used to prioritize newly detected safety issues. Pharmacoepidemiol Drug Saf 2017;26:327-34. [Ref.ID 101955]
17. Cita con resumen
18. Cita con resumen
Nevitt SJ, Marson AG, Davie B, Reynolds S, Williams L, Smith CT. Exploring changes over time and characteristics associated with data retrieval across individual participant data meta-analyses: systematic review. BMJ 2017;357:j1390. [Ref.ID 101632]
Seleccionar todas
 
 1 a 20 de 5690 siguiente >>